Sienna Biopharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2015 | -9.97M | -88K | 14.62M |
|---|---|---|---|
| 2016 | -17.68M | -7.05M | 28.84M |
| 2017 | -41.08M | -266K | 106.77M |
| 2018 | -61.69M | -39K | 35.96M |
| 2019 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 |
SNNAQ Cash Flow Statement (2015 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 0 | 0 | 48.52M | 74.64M | 9.09M | 4.96M | 409K |
Operating activities | ||||||||
Net income | 0 | 0 | 0 | 0 | -73.47M | -50.54M | -21.16M | -11.29M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 0 | 0 | 0 | 0 | 157K | 120K | 67K | 32K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 2.11M | 413K | 111K |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 2.11M | 413K | 111K |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 2.87M | 0 | 720K |
Cash generated by operating activities | 0 | 0 | 0 | 0 | -61.69M | -41.08M | -17.68M | -9.97M |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | -39K | -274K | -238K | -88K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 8K | -6.82M | 0 |
Cash generated by investing activities | 0 | 0 | 0 | 0 | -39K | -266K | -7.05M | -88K |
Financing activities | ||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 6.09M | 66.56M | 0 | 185K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45.39M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.24M |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 3.90M | 0 | -892K |
Cash used in financing activities | 0 | 0 | 0 | 0 | 35.96M | 106.77M | 28.84M | 14.62M |
Net Change In Cash | 0 | 0 | 0 | 0 | -25.94M | 65.37M | 4.12M | 4.55M |
Cash at end of period | 0 | 0 | 0 | 48.52M | 48.70M | 74.46M | 9.09M | 4.96M |